Medicamen Organics Limited is an India-based pharmaceutical company. The Company is engaged in developing, manufacturing and distribution of a range of pharmaceutical dosages, including generic dosage in the form of tablets, capsules, oral liquids, ointments, gels, syrups, suspension, and dry powders for governments (including both state and central governments) and private institutions as contract manufacturer/third party manufacturer. Its product portfolio consists of over 84 products and comprises a range of drugs such as antibacterial, anti-diarrheal, antifungal, anti-malarial, anti-diabetic, proton pump inhibitor, antihistamine, antihypertensive drugs, anti-lipidemic drug, antiparasitic, multivitamin, multimineral and non-steroidal anti-inflammatory drug (NSAIDS). Its products are marketed across India as well as African, CIS and southeast Asian Countries, such as Congo, Benin, Togo, Senegal, Burkina Faso, Philippines, Myanmar, Mozambique, Togo, Burundi, Kyrgyzstan, and Kenya.
MEDICAMEN ORGANICS LTD Financial Highlights
- Revenue: MEDICAMEN ORGANICS LTD reported revenue of ₹22.71 crore in FY26 vs ₹38.29 crore in FY25. It showed a decrease of 40.69% on a yearly basis.
- Operating Profit: MEDICAMEN ORGANICS LTD reported an operating loss of ₹5.28 crore in FY26 vs ₹5.43 crore in FY25. It showed a decrease of 197.24% on a year-on-year basis.
- Net Profit: MEDICAMEN ORGANICS LTD reported a net loss of ₹4.02 crore in FY26 vs ₹4.05 crore in FY25. It showed a decrease of 199.26% on a yearly basis.